Press releases

Scientists at the University of Nottingham have developed a ground-breaking technique to analyse the atomic-level structure of RNA molecules with exceptional precision and speed, and are the first in the world to use the method to examine structural changes in RNA when a cell gets infected with HIV.

Leaders in science, healthcare and industry, along with members of parliament, have come together to mark 20 years of research that has taken place at the University of Nottingham’s Biodiscovery Institute (BDI).

Experts at the University of Nottingham are on the lookout for volunteers for a major new study looking at how physical activity levels affects our bodies as we age.

A new intervention, led by experts in rehabilitation from the University of Nottingham, will look at how to reduce the number of falls experienced by stroke survivors in their homes.

Researchers from the University Nottingham, in partnership with colleagues from the University of Adelaide, have secured a £500,000 grant from Diabetes UK as part of a £1m research project using pioneering neuroimaging techniques to identify how the tongue and digestive tract sense sweet stimuli and integrate this signalling in the brain of people with type 2 diabetes.

A £9.4 million collaborative research centre, involving researchers from the University of Nottingham, will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases.

A significant milestone in the construction of the NHS National Rehabilitation Centre (NRC) was cause for celebration this week for the project partners committed to making the facility a reality.

Experts have developed a new tool, called QR4, that more accurately predicts an individual's ten-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

A new study has found that by offering stop smoking support as part of the national lung cancer screening programme, there is potential to save lives, and dedicated funding must be considered by policy makers.

Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a new study from a collaboration across the Universities of Manchester, Nottingham, Edinburgh and Dundee.